Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Jost

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Acta Haematologica|November 6, 2009
Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemiaReyad Dada, Stefan Wilop, Edgar Jost, et al.
Expert Review of Hematology|June 30, 2018
Germ line predisposition to myeloid malignancies appearing in adulthoodMartina Crysandt, Kira Brings, Fabian Beier, et al.
Journal of Cancer Research and Clinical Oncology|April 29, 2009
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapyStefan Wilop, Sabine von Hobe, Martina Crysandt, et al.
American Journal of Hematology|June 25, 2010
Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML)Iris Middeldorf, Oliver Galm, Rainhardt Osieka, et al.
Onkologie|December 9, 2008
Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancerStefan Wilop, Martina Crysandt, Michael Bendel, et al.
Clinical Epigenetics|June 19, 2012
Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemiaChristoph Oing, Edgar Jost, Edgar Dahl, et al.
Blood|January 30, 2010
Friday leukemia: myth or reality?Stefan Wilop, Oliver Galm, Laura Thompson, et al.
Clinical Epigenetics|September 1, 2012
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutationKarla Bennemann, Oliver Galm, Stefan Wilop, et al.
Scientific Reports|July 15, 2025
Domain-incremental white blood cell classification with privacy-aware continual learningPratibha Kumari, Afshin Bozorgpour, Daniel Reisenbüchler, et al.
Onkologie|October 27, 2010
Antineoplastic chemotherapy in cancer patients with methicillin-resistant Staphylococcus aureus (MRSA)Martina Crysandt, Sebastian W Lemmen, Edgar Jost, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Acta Haematologica|November 6, 2009
Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemiaReyad Dada, Stefan Wilop, Edgar Jost, et al.
Expert Review of Hematology|June 30, 2018
Germ line predisposition to myeloid malignancies appearing in adulthoodMartina Crysandt, Kira Brings, Fabian Beier, et al.
Journal of Cancer Research and Clinical Oncology|April 29, 2009
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapyStefan Wilop, Sabine von Hobe, Martina Crysandt, et al.
American Journal of Hematology|June 25, 2010
Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML)Iris Middeldorf, Oliver Galm, Rainhardt Osieka, et al.
Onkologie|December 9, 2008
Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancerStefan Wilop, Martina Crysandt, Michael Bendel, et al.
Clinical Epigenetics|June 19, 2012
Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemiaChristoph Oing, Edgar Jost, Edgar Dahl, et al.
Blood|January 30, 2010
Friday leukemia: myth or reality?Stefan Wilop, Oliver Galm, Laura Thompson, et al.
Clinical Epigenetics|September 1, 2012
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutationKarla Bennemann, Oliver Galm, Stefan Wilop, et al.
Scientific Reports|July 15, 2025
Domain-incremental white blood cell classification with privacy-aware continual learningPratibha Kumari, Afshin Bozorgpour, Daniel Reisenbüchler, et al.
Onkologie|October 27, 2010
Antineoplastic chemotherapy in cancer patients with methicillin-resistant Staphylococcus aureus (MRSA)Martina Crysandt, Sebastian W Lemmen, Edgar Jost, et al.
Pageof 11